Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Type I interferons play a key role in the development of various skin diseases.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.